40 related articles for article (PubMed ID: 15299835)
1. WIN51711-resistant mutants of poliovirus type 3: capsid residues important in uncoating functions.
Mosser AG; Sgro JY; Rueckert RR
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):490-5. PubMed ID: 15299835
[TBL] [Abstract][Full Text] [Related]
2. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
Mosser AG; Sgro JY; Rueckert RR
J Virol; 1994 Dec; 68(12):8193-201. PubMed ID: 7966611
[TBL] [Abstract][Full Text] [Related]
3. Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14.
Hiremath CN; Grant RA; Filman DJ; Hogle JM
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):473-89. PubMed ID: 15299834
[TBL] [Abstract][Full Text] [Related]
4. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
Shepard DA; Heinz BA; Rueckert RR
J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
[TBL] [Abstract][Full Text] [Related]
5. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
6. The effect of capsid mutations on HIV-1 uncoating.
Wacharapornin P; Lauhakirti D; Auewarakul P
Virology; 2007 Feb; 358(1):48-54. PubMed ID: 16996553
[TBL] [Abstract][Full Text] [Related]
7. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.
Mosser AG; Rueckert RR
J Virol; 1993 Mar; 67(3):1246-54. PubMed ID: 8382293
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterisation of poliovirus mutants resistant to heating at 50 degrees Celsius for 30 min.
Shiomi H; Urasawa T; Urasawa S; Kobayashi N; Abe S; Taniguchi K
J Med Virol; 2004 Nov; 74(3):484-91. PubMed ID: 15368512
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cellular protein secretion by picornaviral 3A proteins.
Choe SS; Dodd DA; Kirkegaard K
Virology; 2005 Jun; 337(1):18-29. PubMed ID: 15914217
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
11. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses.
Crowder S; Kirkegaard K
Nat Genet; 2005 Jul; 37(7):701-9. PubMed ID: 15965477
[TBL] [Abstract][Full Text] [Related]
12. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
13. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
Mo H; Konstantinidis AK; Stewart KD; Dekhtyar T; Ng T; Swift K; Matayoshi ED; Kati W; Kohlbrenner W; Molla A
Virology; 2004 Nov; 329(2):319-27. PubMed ID: 15518811
[TBL] [Abstract][Full Text] [Related]
14. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
Burns CC; Shaw J; Campagnoli R; Jorba J; Vincent A; Quay J; Kew O
J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
[TBL] [Abstract][Full Text] [Related]
15. Substitutions of amino acids in alpha-helix-4 of gyrase A confer fluoroquinolone resistance on Clostridium perfringens.
Rafii F; Park M
Arch Microbiol; 2007 Feb; 187(2):137-44. PubMed ID: 17051403
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.
Ros C; Baltzer C; Mani B; Kempf C
Virology; 2006 Feb; 345(1):137-47. PubMed ID: 16242744
[TBL] [Abstract][Full Text] [Related]
17. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
18. Labeling of capsid proteins and genomic RNA of human rhinovirus with two different fluorescent dyes for selective detection by capillary electrophoresis.
Kremser L; Petsch M; Blaas D; Kenndler E
Anal Chem; 2004 Dec; 76(24):7360-5. PubMed ID: 15595880
[TBL] [Abstract][Full Text] [Related]
19. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
20. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
Dedepsidis E; Pliaka V; Kyriakopoulou Z; Brakoulias C; Levidiotou-Stefanou S; Pratti A; Mamuris Z; Markoulatos P
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):343-51. PubMed ID: 18328076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
